Kurt is the current President of the International Society for Cellular Therapy. He attended Stanford University and the University of Kansas School of Medicine. He completed medical residencies at the University of Kansas and Johns Hopkins. He is board certified in anatomic pathology, clinical pathology, blood banking and transfusion medicine. He completed an immunology fellowship at the US National Institutes of Health. His work experience has included the FDA as a Medical Officer in the Center for Biologics, Deputy Director of the FDA Division of Cell and Gene Therapy, Assistant Professor at Children’s National Medical Center in Washington DC and several leadership positions in private industry (including Transkaryotic and ViaCell). At ViaCell he was Medical Director of the Viacord Cord Blood Bank. He is currently VP for Clinical Development at Hospira Inc. He is an active member of several other societies active in cell therapy and regenerative medicine including AABB, International Society for Stem Cell Research (Commercial Committee), American Society of Hematology, American Society for Blood and Marrow Transplantation, and the FDA Cell, Tissue and Gene Therapy Advisory Committee (3-year term as Industry Representative).   Kurt is the current President of the International Society for Cellular Therapy. He attended Stanford University and the University of Kansas School of Medicine. He completed medical residencies at the University of Kansas and Johns Hopkins. He is board certified in anatomic pathology, clinical pathology, blood banking and transfusion medicine. He completed an immunology fellowship at the US National Institutes of Health. His work experience has included the FDA as a Medical Officer in the Center for Biologics, Deputy Director of the FDA Division of Cell and Gene Therapy, Assistant Professor at Children’s National Medical Center in Washington DC and several leadership positions in private industry (including Transkaryotic and ViaCell). At ViaCell he was Medical Director of the Viacord Cord Blood Bank. He is currently VP for Clinical Development at Hospira Inc. He is an active member of several other societies active in cell therapy and regenerative medicine including AABB, International Society for Stem Cell Research (Commercial Committee), American Society of Hematology, American Society for Blood and Marrow Transplantation, and the FDA Cell, Tissue and Gene Therapy Advisory Committee (3-year term as Industry Representative).  

Genetics and Molecular Biology